Acusera 24•7 (Edit)
Acusera 24•7 (Edit)
Designed to complement our range of true third party controls, Acusera 24•7 is a live, cloud based interlaboratory data management and peer group reporting software, intended to assist in the management of daily QC activities.
Why implement an interlaboratory program?
- With real-time peer group data, laboratories can instantly compare statistics to other labs using the same lot of QC material.
- Acusera 24•7 boasts a unique dashboard, allowing for instant identification of any QC failures over the past seven days and alerts of product expiry.
- Automatically calculate %Bias, Total Error and Sigma Metrics, enabling enhanced performance assessment and improved QC strategy design.
- Acusera 24•7 generates Levey-Jennings, Histogram and Performance Summary Charts for efficient performance monitoring.
- Designed to speed up the review process, our comprehensive range of easy-to-read reports include: Statistical Metrics, Uncertainty of Measurement and Audit Trails.
- Automated upload of QC data direct to Acusera 24•7 via LIMS and Middleware is available. This function eliminates the need for manual data entry further increasing efficiency.
- Software flexibility allows laboratories to configure their own performance limits, multi-rules, consensus groups and target values for each instrument or QC lot.
- This cloud based software is available for laboratories to access anytime, anywhere therefore eliminating the need for installation, software maintenance and frequent back ups.
Why implement an interlaboratory program?
Randox International Quality Assessment Scheme (RIQAS)
RIQAS is the world’s largest External Quality Assessment scheme with more than 50,000 laboratory participants spanning over 139 countries
Why Choose RIQAS?
- Our rapid, user-friendly reports allow at-a-glance performance assessment. Complimentary multi-instrument, inter-laboratory and end-of-cycle reports are also available.
- The availability of large peer groups ensures robust data is available for a wide range of instruments and methods.
- Consolidate EQA analysis, reduce workload and costs with our comprehensive, multi-parameter programmes.
- Frequent reporting allows early identification of test system errors, while our 72 hour report turnaround enables corrective action to be taken with minimum disruption to the lab.
- Flexible programme options are available to suit all laboratory budgets. The option to register up to 5 instruments per programme at no extra fee further reduces costs and facilitates comparative performance assessment.
- RIQAS.net is a convenient, cloud based data entry system which allows participants to return results and view reports online.
- RIQAS programmes are accepted by national and international accreditation bodies including ISO 17043:2010 – “Conformity Assessment – General Requirements for Proficiency Testing”.
- EQA samples are manufactured to the highest quality standard and span clinically relevant levels. A commutable sample matrix increases confidence that performance mimics that of patient samples.
RIQAS EQA Programmes
Choice & flexibility are guaranteed with our 33 programme portfolio.
Browse the programmes below
RIQAS EQA Reports
User-friendly, one-page per parameter reports allow for at-a-glance performance assessment.
Browse the reports below.
Ideal specifications of an External Quality Assessment provider
External Quality Assessment retrospectively assesses performance against other laboratories using the same method and instrument, by analysing “blind” samples as if they were patient samples. Results are frequently submitted for statistical analysis, following which each lab will receive an overall comparative report. Find out why EQA is important here.
Continue Reading
RIQAS FAQs
RIQAS Past Panels
RIQAS Brochure
Contact Us
Acusera 24.7 Software Update
The latest update of Acusera 24.7 allows RX Imola, Modena and Daytona+ users to import compatible QC files from a configured analyser to Acusera 24.7 without the need for manipulation. This new functionality eliminates the need for manual data entry, therefore effectively reducing the risk of transcription errors whilst speeding up the reporting process.
Acusera 24•7 | Update Features
Our brand new Acusera 24.7 video is here! Take a look now
Want to know more?
Contact us or download our Acusera 24.7 brochure today.
Continue Reading
Acusera 24.7 FAQs
Resource Hub
Quality Controls
RIQAS Past Panels
RIQAS (Randox International Quality Assessment Scheme) is the largest global EQA scheme with over 50,000 participants in more than 139 countries. Our range currently comprises 33 programmes and the majority of clinical testing.
What are RIQAS Past Panels?
Available Panels
• Ammonia/ Ethanol
• Anti-TSH Receptor
• Blood Gas
• BNP
• Cardiac
• Cerebrospinal Fluid (CSF)
• Clinical Chemistry
• Coagulation
• CO-Oximetry
• CYFRA 21-1
• ESR
• Glycated Haemoglobin (HbA1c)
• Haematology
• Human Urine
• Immunoassay
• Immunoassay Speciality 1
• Immunoassay Speciality 2
• Immunosuppressant Drugs
• Lipid
• Liquid Cardiac
• Maternal Screening
• Serology Epstein Barr Virus (EBV)
• Serology (HIV/ Hepatitis)
• Serology (Syphilis)
• Serology (ToRCH)
• Specific Proteins
• Sweat Testing
• Therapeutic Drugs
• Trace Elements in Blood
• Trace Elements in Serum
• Trace Elements in Urine
• Urinalysis
• Urine Toxicology
*Product availability is dependent on RIQAS stock surplus levels.
Benefits of RIQAS Past Panels
All RIQAS Past Panels are provided with an Excel document containing supporting data for the instrument and method of interest.
RIQAS Past Panel samples span multiple levels, making them ideal for ensuring accurate instrument performance across the measuring range.
RIQAS Past Panels allow laboratories to receive comprehensive external QC reports even after program close.
Acusera 24.7
Designed to complement our range of Acusera true third party controls, Acusera 24•7 is a live, cloud based interlaboratory data management and peer group reporting software, intended to assist in the management of daily QC activities.
Why implement an interlaboratory program?
Acusera 24•7 | Key Features and Benefits
Click each icon for full features and benefits
Peer Group Statistics
With real-time peer group data, laboratories can instantly compare statistics to other labs using the same lot of QC material. Data is continuously updated, allowing labs to identify unique and widespread issues to help reduce time and money spent on troubleshooting, re-running samples and performing instrument maintenance.
Unique Dashboard Interface
Acusera 24•7 boasts a unique dashboard, allowing for instant identification of any QC failures over the past seven days and alerts of product expiry. The interface is designed to reduce the time spent analysing data, meaning corrective action can be taken immediately with minimum disruption to laboratory output.
Advanced Statistical Analysis
Automatically calculate %Bias, Total Error and Sigma Metrics, enabling enhanced performance assessment and improved QC strategy design. Reject or alert data based on QC multi-rules or user defined performance limits including Rilibak, CLIA and biological variation. Uncertainty of Measurement (UM) is also calculated, helping meet ISO 15189 requirements.
Fully Interactive Charts
Acusera 24•7 generates Levey-Jennings, Histogram and Performance Summary Charts for efficient performance monitoring. Users can add multiple instruments, parameters and lots to a single chart to compare performance and assess emerging trends. Laboratories can review data for date ranges, explore individual data points and record events.
Comprehensive Reports
Designed to speed up the review process, our comprehensive range of easy-to-read reports include: Statistical Metrics Reports, Uncertainty of Measurement Report, Exception Report, and an Audit Trail Report. Reports can be customised for specific date ranges and filtered to display individual test or instrument data.
Automated Data Import
This optional software allows for automated upload of QC data direct to Acusera 24•7 via LIMS and Middleware. This function eliminates the need for manual data entry, further saving costs and increasing efficiency.
Highly Flexible
Software flexibility allows laboratories to configure their own performance limits, multi-rules, consensus groups and target values for each instrument or QC lot. This software’s internal functions can be used with any manufacturer’s QC material.
24/7 Access
This cloud based software is available for laboratories to access anytime, anywhere therefore eliminating the need for installation, software maintenance and frequent back ups. Access Acusera 24•7 here.
Technical Support
With Acusera 24•7, expert technical support is available from our team of highly trained specialists. Laboratories can remotely access the technical support service for immediate troubleshooting, therefore eliminating the need for on-site assistance.
Want to know more?
Contact us or download our Acusera 24.7 brochure today.
Related Products
Continue Reading
Acusera 24.7 FAQs
Resource Hub
Quality Controls
Protected: QCMD – Molecular External Quality Control (NEW)
RX series (Concept 3)
The RX series range of clinical chemistry analysers includes both semi-automated and fully automated testing for a range of clinical settings. With a world leading test menu comprising of routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing, the RX series offers laboratories the complete clinical chemistry package and results you can trust. The RX series was built with three core values in mind – Reliability, Accuracy and Precision.
Consolidation of Routine & Specialised Testing on One Single Platform
With an extensive product portfolio covering over 100 disease markers within routine and nice testing, the RX series removes the need for a separate nephelometry system for specific proteins and allows laboratories to bring all testing in-house; thus ensuring minimal downtime and providing real cost savings through consolidation.
Low Reagents & Sample Volumes
Built with excellence in mind, the RX series range of analsyers require a low sample volume to deliver consistent high quality results which is beneficial when working with paediatric patients and animals. Combined with our high quality reagents, the RX series reduce the possibility of misdiagnoses, offering accurate, reliable and precise results each time, every time.
Unrivalled Customer Support
Our team of trained engineers are on hand to work with you in preserving the continuity of your operations while maximising the potential of your RX series instrument. We know time is critical in any laboratory and our global network means we are uniquely positioned to meet your needs with local service and support whenever you need it.
Fully Automated
Test Menu
Semi-Automated
Test Menu
Niche
Test Menu
QCMD – Molecular External Quality Control
QCMD is a world leading External Quality Assessment (EQA) / Proficiency Testing (PT) scheme, dedicated to improving the quality of molecular diagnostic assays used in the detection of infectious diseases.
With an extensive database of over 2000 participants in over 100 countries, QCMD is one of the largest providers of molecular EQA in the field of molecular diagnostics.
Frequency
A variety of programme options are available. Choose the number of challenges that best suit your laboratory’s requirements.
Online EQA Management System
ITEMS provides an online tool to easily manage all EQA activities from programme registration to submission of results and provision of EQA reports. Different levels of user access are available so data can be accessed by whoever needs it.
High level of participation
Over 2000 participants in more than 100 countries ensuring peer group numbers are maximised.
Comprehensive reports
Receive individual reports for each challenge and a final supplementary report at the end of the cycle visual assessment of performance.
International accreditation
Programmes are accredited to ISO 17043.
- Blood Borne Viruses
- Central Nervous System Diseases
- Drug Resistance
- Exotic / Emerging Diseases
- Gastrointestinal Diseases
- Immunocompromised Associated Diseases
- Multiple Pathogen / Syndromic Infections
- Respiratory Diseases
- Serology
- Sexually Transmitted Infections
- Transplant Associated diseases
- Typing
- New Pilot Studies
After the close of the results return phase, EQA participants will receive an individual report outlining their performance relative to their method and technology groups. A supplementary report may be commissioned – this includes any additional relevant information regarding the annual EQA distribution, as well as scientific expert commentary and feedback on the overall results within that distribution.